To tell or not to tell: Why people with HIV share or don't share with their physicians whether they are taking their medications as prescribed

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue 5, 2006, Pages 520-528

  Kremer, H ^a   Ironson, G ^a  

^a Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CHRONIC DISEASE; CONTENT ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MORALITY; PATIENT INFORMATION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SURVIVAL RATE; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; DECISION MAKING; FEMALE; FLORIDA; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MOTIVATION; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; SEXUAL BEHAVIOR; TRUTH DISCLOSURE;

EID: 33745295868     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600766020     Document Type: Article

References (44)

1. AIDS Clinical Trials Group (2001). ACTG adherence follow-up questionnaire. Available at: http://www.caps.ucsf.edu/projects/2098.4188.pdf.
2. Alberdi Leniz, A., Tuset Creus, M., Martin Conde, M., del Cacho del Cacho, E., Nigorra Caro, M., Codina Jane, C., et al. (2004). Resistance to antiretroviral therapy. Farmacia Hospitalania, 28, S55-S71.
3. Bakeman, R., & Gottmann, J.M. (1986). Observing interaction: An introduction to sequential analysis. Cambridge, England: Cambridge University Press.
4. Barry, C.A., Bradley, C.P., Britten, N., Stevenson, F.A., & Barber, N. (2000). Patients' unvoiced agendas in general practice consultations: A qualitative study. British Medical Journal (Clinical Research edition.), 320, 1246-1250.
5. Bogart, L.M., Catz, S.L., Kelly, J.A., & Benotsch, E.G. (2001). Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Medical Decision Making, 21, 28-36.
6. Carrieri, M.P., Chesney, M.A., Spire, B., Loundou, A., Sobel, A., Lepeu, G., et al. (2003). Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioral Medicine, 10, 1-14.
7. Carrieri, M.P., Raffi, F., Lewden, C., Sobel, A., Michelet, C., Cailleton, V., et al. (2003). Impact of early versus late adherence to highly active antiretroviral therapy on immunovirological response: A three-year follow-up study. Antiviral Therapy, 8, 585-594.
8. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169-177.
9. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group. AIDS Care, 12, 255-266.
10. Chesney, M.A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science & Medicine, 50, 1599-1605.
11. Clerici, M., Seminari, E., Maggiolo, F., Pan, A., Migliorino, M., Trabattoni, D., et al. (2002). Early and late effects of highly active antiretroviral therapy: A two-year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients. AIDS, 16, 1767-1773.
12. Crespo-Fierro, M. (1997). Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care, 8, 43-54.
13. Department of Health and Human Services (US). (2003). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://www.aidsinfo.nih.-gov/guidelines.
14. Fowler, M.E. (1998). Recognizing the phenomenon of readiness: Concept analysis and case study. The Journal of the Association of Nurses in AIDS Care, 9, 72-76.
15. Gallant, J.E. (2004). Editorial comment: Strategies for success - a return to 'hit early'? The AIDS Reader, 14, 662-663.
16. Gallant, J.E., & Block, D.S. (1998). Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. Journal of the International Association of Physicians in AIDS Care, 4, 32-35.
17. Golin, C.E., Liu, H., Hays, R.D., Miller, L.G., Beck, C.K., Ickovics, J., et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
18. Harrigan, P.R., Hogg, R.S., Dong, W.W., Yip, B., Wynhoven, B., Woodward, J., et al. (2005). Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal of Infectious Diseases, 191, 339-347.
19. Hays, W.L. (1981). Statistics (3rd edition). New York, NY: Dyden Press.
20. Hirsch, M.S., & Sterritt, C. (2003). Conference report. Early versus late initiation of antiretroviral therapy for HIV infection: A scientific roundtable meeting. Medscape HIV/AIDS, 9. Available at: http://www.medscape.com/ viewarticle/463372.
21. Ironson, G., Balbin, E., Solomon, G., Fahey, J., Klimas, N., Schneiderman, N., et al. (2001). Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS, 15, 2065-2073.
22. Ironson, G., Solomon, G.F., Balbin, E.G., O'Cleirigh, C., George, A., Kumar, M., et al. (2002). The Ironson-Woods spirituality/religiousness index is associated with long survival, health behaviors, less distress and low cortisol in people with HIV/AIDS. Annals of Behavioral Medicine, 24, 34-48.
23. Ironson, G., Balbin, E., Stuetzle, R., Fletcher, M.A., O'Cleirigh, C., Laurenceau, J. P., et al. (2005a). Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: Proactive behavior, avoidant coping and depression. International Journal of Behavioral Medicine, 12, 86-97.
24. Ironson, G., O'Cleirigh, C., Fletcher, M.A., Laurenceau, J.P., Balbin, E., Klimas, N., et al. (2005b). Psychosocial factors predict CD4 and viral load change in men and women with HIV in the era of HAART. Psychosomatic Medicine, 67, 1013-1021.
25. Kremer, H. (2001). Compliance with HIV-therapy under the aspect of patient's autonomy. Master's thesis. Available at: http://www.soc.psy.ruhr-uni- bochum.de/publikationen_und_-berichte/Diplomarbeiten.htm
26. Kremer, H., Ironson, G., Schneiderman, N., & Hautzinger, M. (2004a). To take or not to take ART: Decision-making criteria used by people with HIV/AIDS, their involvement in the decision-making process and the quality of decision-making. XV International AIDS Conference, Bangkok, Thailand, (ThPeD7693).
27. Kremer, H., Bader, A., O'Cleirigh, C., Bierhoff, H.W., & Brockmeyer, N.H. (2004b). The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership? European Journal of Medical Research, 9, 61-70.
28. Kremer, H. (2005). Medical decision-making, adherence and quality of life in people living with HIV/AIDS. Doctoral thesis. Available at: http://w210.ub.uni-tuebingen.de/dbt/volltexte/2005/1853/.
29. Kremer, H., Ironson, G., Schneiderman, N., & Hautzinger, M. (inpress) To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care and STDs.
30. Laws, M.B., Wilson, I.B., Bowser, D.M., & Kerr, S.E. (2000). Taking antiretroviral therapy for HIV infection: Learning from patients' stories. Journal of General Internal Medicine, 15, 848-858.
31. Liu, H., Golin, C.E., Miller, L.G., Hays, R.D., Beck, C.K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
32. Mayring, P. (2000a). Qualitative content analysis: basics and techniques, (7th edition). Weinheim, Germany: Deutscher Studien Verlag.
33. Mayring, P. (2000b). Qualitative content analysis. Forum: Qualitative Social Research, 1(2). Available at: http://www.qualitative-research.net/fqs.
34. McPherson-Baker, S., Jones, D., Duran, R.E., Klimas, N., & Schneiderman, N. (2005). Development and implementation of a medication adherence training instrument for persons living with HIV: The MATI. Behavior Modification, 29, 286-317.
35. Mruck, K., Mey, G. (2000). Qualitative research in Germany. Forum: Qualitative Social Research. Available at: http://www.qualitative-research.net/ fqs-texte/1-00/1-00mruck-e.htm.
36. Negredo, E., Paredes, R., Bonjoch, A., Tuldra, A., Fumaz, C.R., Gel, S., et al. (1999). Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome: Interim analysis at three-months follow-up. Antiviral Therapy, 4, S23-S28.
37. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
38. Phillips, A.N., Lepri, A.C., Lampe, F., Johnson, M., & Sabin, C.A. (2003). When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies. AIDS, 17, 1863-1869.
39. Proschaska, J.O., & Diclemente, C.C. (1992). Stage of change in the modification of problem behaviors. In M. Hersn, R. M. Eisler, & P. M. Miller (Eds.), Progress in behavior modification. Newbury Park, CA: Sage.
40. Turner, B.J., & Hecht, F.M. (2001). Improving on a coin toss to predict patient adherence to medications. Annals of Internal Medicine, 134, 1004-1006.
41. Volberding, P. (2000). When and where to start: Guidelines for the initiation of antiretroviral therapy. AIDS Reader, 10(3), 150-155; discussion 171-174.
42. Walsh, J.C., Horne, R., Dalton, M., Burgess, A.P., & Gazzard, B.G. (2001). Reasons for non-adherence to antiretroviral therapy: Patients' perspectives provide evidence of multiple causes. AIDS Care, 13, 709-720.
43. Wenger, N., Gifford, A., Liu, H., Chesney, M., Golin, C., Crystal, S., et al. (1999). Patient characteristics and attitudes associated with antiretroviral adherence. Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Abstract, 98.
44. Wood, E., Hogg, R.S., Harrigan, P.R., & Montaner, J.S. (2005). When to initiate antiretroviral therapy in HIV-infected adults: A review for clinicians and patients. Lancet Infectious Diseases, 5, 407-414.